## ROL: Rollins, Inc. - XLY: Consumer Cyclical

### Executive Summary

No thesis match: MRS_10 -0.1% below STRENGTH zone (3.0-6.0%); PEG 3.94 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-3.7% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($58.47)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 1
- **Sentiment:** Bullish (Bullish: 1, Bearish: 0)

**1. RBC Raises Price Target on Rollins to $70 From $62, Keeps Outperform Rating**
- Source: marketscreener.com | 20251223T120806 | Bullish | Relevance: 100%
- RBC has increased its price target on Rollins (NYSE: ROL) to $70 from $62, while maintaining an Outperform rating. This adjustment suggests a positive outlook from the analyst firm regarding the pest control services provider's future performance. The article also notes other recent analyst actions and company news for Rollins.

### Analyst Activity

**Target Signal:** VERY_BULLISH (Raises: 2, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-17 | Morgan Stanley | $72 | $58 | +24% |
| 2025-12-05 | Barclays | $72 | $60 | +20% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-17 | Morgan Stanley | up | Overweight |
| 2025-12-05 | Barclays | up | Overweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 0 ($0.00M) |
| Sells | 7 ($3296.08M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 24.4% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 4 |

**Top Holders:**
- Vanguard Group Inc: 7.6% (+4.2%)
- Blackrock Inc.: 6.0% (+1.2%)
- State Street Corpora: 2.5% (+1.4%)
- Kayne Anderson Rudni: 2.0% (-2.8%)
- Geode Capital Manage: 2.0% (+1.7%)

### Key Risks

1. Momentum deterioration: MRS_10 falling (-3.7% 5d) with bearish MACD, trend may be turning.
2. Heavy insider selling: $3296M sold (7 transactions in 90 days).
3. Valuation stretched: PEG 3.9x requires aggressive growth execution.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 3.94 signals overvaluation risk, limited margin of safety. Forward P/E 47.5x stretched relative to 12% growth. Quality metrics strong (ROE 36%, ROA 15%). Analyst sentiment positive (2 raises, avg +22%). Insider selling cluster ($3296.1M in 90 days), potential headwind. Institutional flow bullish (5 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $29.2B |
| Beta | 0.79 |
| 52W Range | $45.34 - $61.84 |
| Short Interest | 3.3% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 3.94 |
| Forward P/E | 47.5 |
| Current P/E | 53.2 |
| YoY Growth | 12.0% |
| EPS Direction | STABLE |

### Technicals

MRS_10 deteriorating from 3.6% to -0.1% (-3.7% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 3.1pp (needs >3.0% for momentum thesis). Full SMA alignment bullish (above 20/50/200 SMAs). RSI neutral at 56. OFD pattern: -MTL (Decline).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -0.11% (CS: 67) | Neutral |
| RSI_14 | 56.0 | Neutral |
| MACD Histogram | -0.01 | Bearish |
| vs SMA20 | 1.006x | Above |
| vs SMA50 | 1.034x | Above |
| vs SMA200 | 1.070x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $60.73
- **Stop Loss:** $58.47 (3.7% risk)
- **Target:** $62.99 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 398
- **Position Value:** $24,170.54
- **Portfolio %:** 24.17%
- **Risk Dollars:** $900.00
- **Risk Per Trade:** 0.90%
- **Modifiers:** L1 120% | L2 75% | Combined 0.90x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | WEAKENING (Zone B) | 0.75x |

*NORMAL regime with moderate risk appetite in holiday-thinned conditions. VIX at 52-week lows suggests complacency, but modest breadth improvement and stable yields indicate underlying stability. Focus on quality positioning ahead of 2026 catalysts.*

### Earnings

**Next:** 2026-02-18 (Est: $0.27)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.33 | $0.35 | +6.3% |
| 2025Q2 | $0.30 | $0.30 | -0.7% |
| 2025Q1 | $0.22 | $0.22 | +1.3% |
| 2024Q4 | $0.23 | $0.23 | -0.8% |

---
*RULE-based L3 | 2026-01-06 16:38 | MRS_10*